We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+16.59%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$2.17B
AUM Growth
+$356M
Cap. Flow
+$106M
Cap. Flow %
4.87%
Top 10 Hldgs %
32.24%
Holding
194
New
14
Increased
88
Reduced
77
Closed
13

Top Buys

Rank Stock Value
1
CHGG icon
Chegg
CHGG
+$49.1M
2
EHTH icon
eHealth
EHTH
+$22.4M
3
SPT icon
Sprout Social
SPT
+$22M
4
ENPH icon
Enphase Energy
ENPH
+$19.1M
5
ZS icon
Zscaler
ZS
+$12.8M

Top Sells

Rank Stock Value
1
CARB
Carbonite Inc
CARB
+$18.1M
2
COUP
Coupa Software Incorporated
COUP
+$16.6M
3
ETSY icon
Etsy
ETSY
+$15.1M
4
TDOC icon
Teladoc Health
TDOC
+$11.3M
5
MDCO
Medicines Co
MDCO
+$11.1M

Sector Composition

Rank Sector Weight
1 Technology 34.59%
2 Healthcare 20.01%
3 Industrials 12.27%
4 Consumer Discretionary 8.61%
5 Consumer Staples 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CIEN icon
151
Ciena
CIEN
$58.4B
$1.39M 0.06%
+32,475
New +$1.24M
CTMX icon
152
CytomX Therapeutics
CTMX
$754M
$1.28M 0.06%
153,818
+421
+0.3% +$2.84K
SHSP
153
DELISTED
SharpSpring, Inc.
SHSP
$1.26M 0.06%
109,876
+50,538
+85% +$515K
LGND icon
154
Ligand Pharmaceuticals
LGND
$6.36B
$1.24M 0.06%
19,109
-13,842
-42% -$925K
ORGO icon
155
Organogenesis Holdings
ORGO
$239M
$1.2M 0.06%
+250,000
New +$1.58M
ITRM
156
DELISTED
Iterum Therapeutics
ITRM
$1.1M 0.05%
16,298
+150
+0.9% +$7.32K
JNCE
157
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.07M 0.05%
122,282
-630
-0.5% -$3.4K
MTCH icon
158
Match Group
MTCH
$8.55B
$958K 0.04%
11,671
-1,179
-9% -$85.8K
AAN.A
159
DELISTED
The Aaron's Company Inc Class A
AAN.A
$898K 0.04%
+15,717
New +$898K
NTLA icon
160
Intellia Therapeutics
NTLA
$1.67B
$882K 0.04%
60,107
+416
+0.7% +$5.79K
VRNS icon
161
Varonis Systems
VRNS
$5B
$877K 0.04%
+33,846
New +$804K
SGMO
162
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$859K 0.04%
102,635
+1,016
+1% +$9.34K
ETTX
163
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$780K 0.04%
156,944
+15,932
+11% +$86.2K
AKTS
164
DELISTED
Akoustis Technologies Inc
AKTS
$768K 0.04%
96,038
-2,849
-3% -$22.3K
DDOG icon
165
Datadog
DDOG
$84B
$735K 0.03%
+19,464
New +$700K
PODD icon
166
Insulet
PODD
$9.79B
$599K 0.03%
3,499
-28,686
-89% -$4.78M
MMSI icon
167
Merit Medical Systems
MMSI
$5.32B
$557K 0.03%
17,850
-31,225
-64% -$894K
TACT icon
168
Transact Technologies
TACT
$58.6M
$454K 0.02%
41,399
+5,435
+15% +$62.3K
RP
169
DELISTED
RealPage, Inc.
RP
$386K 0.02%
7,185
+2,271
+46% +$129K
TTOO
170
DELISTED
T2 Biosystems, Inc
TTOO
$374K 0.02%
64
+20
+45% +$189K
NBRV
171
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$352K 0.02%
1,066
+122
+13% +$56K
TRTN
172
DELISTED
Triton International Limited
TRTN
$344K 0.02%
8,559
-14,121
-62% -$523K
ZAGG
173
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$340K 0.02%
+41,965
New +$312K
COLL icon
174
Collegium Pharmaceutical
COLL
$956M
$333K 0.02%
16,187
-24,519
-60% -$409K
LYV icon
175
Live Nation Entertainment
LYV
$42.1B
$320K 0.01%
4,475
-2,273
-34% -$154K
4 5 6
7
8

Similar funds

HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Granahan Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, Granahan Investment Management held 194 positions worth $2.17B, up 20% from $1.82B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Granahan Investment Management deployed $106M of net new capital in Q4 2019, opening 14 new positions and adding to 88 existing holdings. Its largest new stake was Sprout Social: 1,352,277 shares worth $21.7M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Coupa Software Incorporated, an estimated $16.6M trimmed.

  • Granahan Investment Management's largest Q4 2019 buy was Sprout Social: 1,352,277 shares worth $21.7M.
  • Granahan Investment Management added most to Chegg in Q4 2019, an estimated $49.1M increase.
  • Granahan Investment Management's biggest Q4 2019 reduction was Coupa Software Incorporated, cutting an estimated $16.6M.
  • Granahan Investment Management fully exited Carbonite Inc in Q4 2019, selling an estimated $18.1M.
  • Granahan Investment Management's ten largest holdings make up 32% of its $2.17B portfolio in Q4 2019.
  • Granahan Investment Management opened 14 new positions and closed 13 in Q4 2019.
  • Granahan Investment Management's portfolio value rose 20% quarter-over-quarter to $2.17B.

Based on Granahan Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.